These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 30899966)

  • 41. The role of N-terminal PRO-brain natriuretic peptide and echocardiography for screening asymptomatic left ventricular dysfunction in a population at high risk for heart failure. The PROBE-HF study.
    Betti I; Castelli G; Barchielli A; Beligni C; Boscherini V; De Luca L; Messeri G; Gheorghiade M; Maisel A; Zuppiroli A
    J Card Fail; 2009 Jun; 15(5):377-84. PubMed ID: 19477397
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Sensitive cardiac troponins and N-terminal pro-B-type natriuretic peptide in stable coronary artery disease: correlation with left ventricular function as assessed by myocardial strain.
    Smedsrud MK; Gravning J; Omland T; Eek C; Mørkrid L; Skulstad H; Aaberge L; Bendz B; Kjekshus J; Edvardsen T
    Int J Cardiovasc Imaging; 2015 Jun; 31(5):967-73. PubMed ID: 25788439
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of silent coronary artery disease in type 2 diabetes.
    Zellweger MJ
    Herz; 2006 May; 31(3):240-5. PubMed ID: 16770561
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Can myocardial performance index predict the presence of silent ischemia in asymptomatic type 2 diabetic patients?
    Al-Daydamony MM; El-Tahlawi MA; Shawky A
    Echocardiography; 2016 Dec; 33(12):1823-1827. PubMed ID: 27677770
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Silent myocardial infarction and risk of heart failure: Current evidence and gaps in knowledge.
    Soliman EZ
    Trends Cardiovasc Med; 2019 May; 29(4):239-244. PubMed ID: 30224236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Silent myocardial ischemia in patients with diabetes: who to screen.
    Janand-Delenne B; Savin B; Habib G; Bory M; Vague P; Lassmann-Vague V
    Diabetes Care; 1999 Sep; 22(9):1396-400. PubMed ID: 10480499
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Myocardial ischemia: a silent epidemic in Type 2 diabetes patients.
    Le Feuvre C; Jacqueminet S; Barthelemy O
    Future Cardiol; 2011 Mar; 7(2):183-90. PubMed ID: 21453025
    [TBL] [Abstract][Full Text] [Related]  

  • 48. N-terminal-proB natriuretic peptide in patients with stable coronary artery disease evaluated for ischemia with myocardial perfusion imaging.
    Majstorov V; Pop GD; Vavlukis M; Peovska I; Maksimovik J; Vaskova O; Kuzmanovska S; Zdraveska-Kochovska M
    Bratisl Lek Listy; 2008; 109(7):293-7. PubMed ID: 18792482
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preprocedural N-terminal pro-B-type natriuretic peptide as a useful marker for predicting periprocedural myocardial injury following percutaneous coronary intervention in diabetic patients without cardiac dysfunction.
    Zeng RX; Li XL; Zhang MZ; Wang XW; Guo YL; Zhu CG; Ren Y; Li S; Zhang Y; Liu G; Xu RX; Dong Q; Li JJ
    Scand J Clin Lab Invest; 2015 Nov; 75(7):568-77. PubMed ID: 26203960
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD; Verouden NJ; Kuijt WJ; Koch KT; Van Straalen JP; Fischer J; Groenink M; Bilodeau L; Tijssen JG; Krucoff MW; De Winter RJ
    Am J Cardiol; 2010 Apr; 105(8):1065-9. PubMed ID: 20381654
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Noninvasive detection of silent coronary artery disease in patients with essential hypertension, alone or associated with type 2 diabetes mellitus, using dipyridamole stress 99mtechnetium-sestamibi myocardial perfusion imaging.
    Lacourcière Y; Côté C; Lefebvre J; Dumont M
    Can J Cardiol; 2006 Feb; 22 Suppl A():16A-21A. PubMed ID: 16485055
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sorting out the evidence on natriuretic peptides.
    McCullough PA; Sandberg KR
    Rev Cardiovasc Med; 2003; 4 Suppl 4():S13-9. PubMed ID: 14564224
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there a role for screening asymptomatic patients with diabetes?
    Veillet-Chowdhury M; Blankstein R
    Expert Rev Cardiovasc Ther; 2015 Jun; 13(6):589-91. PubMed ID: 25979367
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Acute changes in N-terminal pro-brain natriuretic peptide induced by dobutamine stress echocardiography.
    Karabinos I; Karvouni E; Chiotinis N; Papadopoulos A; Simeonidis P; Tsolas O; Katritsis D
    Eur J Echocardiogr; 2007 Aug; 8(4):265-74. PubMed ID: 16849043
    [TBL] [Abstract][Full Text] [Related]  

  • 55. N-terminal pro-B-type natriuretic peptide for predicting coronary disease and left ventricular hypertrophy in asymptomatic CKD not requiring dialysis.
    DeFilippi CR; Fink JC; Nass CM; Chen H; Christenson R
    Am J Kidney Dis; 2005 Jul; 46(1):35-44. PubMed ID: 15983955
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Biomarkers and diagnostics in heart failure.
    Gaggin HK; Januzzi JL
    Biochim Biophys Acta; 2013 Dec; 1832(12):2442-50. PubMed ID: 23313577
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Mechanical dispersion as a marker of left ventricular dysfunction and prognosis in stable coronary artery disease.
    Kvisvik B; Aagaard EN; Mørkrid L; Røsjø H; Lyngbakken M; Smedsrud MK; Eek C; Bendz B; Haugaa KH; Edvardsen T; Gravning J
    Int J Cardiovasc Imaging; 2019 Jul; 35(7):1265-1275. PubMed ID: 31165941
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Long-Term Prognostic Value of Coronary CT Angiography in Asymptomatic Type 2 Diabetes Mellitus.
    Kang SH; Park GM; Lee SW; Yun SC; Kim YH; Cho YR; Park HW; Suh J; Yang DH; Kang JW; Lim TH; Jung CH; Koh EH; Lee WJ; Kim MS; Lee KU; Park JY
    JACC Cardiovasc Imaging; 2016 Nov; 9(11):1292-1300. PubMed ID: 27639757
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Poststress left ventricular ejection fraction is an independent predictor of major cardiac events in patients with coronary artery disease and impaired left ventricular function.
    De Winter O; Van De Veire N; De Bondt P; Van De Wiele C; De Buyzere M; De Backer G; Gillebert TC; Dierckx RA; De Sutter J
    Q J Nucl Med Mol Imaging; 2008 Sep; 52(3):296-304. PubMed ID: 17220816
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.